ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

p53MVA therapy in patients with refractory gastrointestinal malignancies elevates p53-specific CD8+ T-cell responses.

Nicola R Hardwick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.